Day One Biopharmaceuticals, Inc. (DAWN)
NASDAQ: DAWN · Real-Time Price · USD
21.20
+8.42 (65.88%)
At close: Mar 6, 2026, 4:00 PM EST
21.16
-0.04 (-0.19%)
After-hours: Mar 6, 2026, 7:58 PM EST
Revenue by Segment
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
|---|
Identification, Development and Commercialization of Medicines | 158.18M | 131.16M | - | - | - | | |
Identification, Development and Commercialization of Medicines Growth | 20.60% | - | - | - | - | | |
| 158.18M | 131.16M | - | - | - | | |
| 20.60% | - | - | - | - | | |
Revenue by Geography
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
|---|
| 158.18M | 131.16M | - | - | - | | |
| 20.60% | - | - | - | - | | |
| 158.18M | 131.16M | - | - | - | | |
| 20.60% | - | - | - | - | | |
Source: S&P Global Market Intelligence.
